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Abstract
Myeloid derived suppressor cells (MDSCs), which suppress anti-tumor or anti-viral immune
responses, are expanded in the peripheral blood and tissues of patients/animals with cancer
or viral infectious diseases. We here show that in chronic SIV infection of Indian rhesus
macaques, the frequency of MDSCs in the bone marrow (BM) was paradoxically and unex-
pectedly decreased, but increased in peripheral blood. Reduction of BM MDSCs was found
in both CD14+MDSC and Lin-CD15+MDSC subsets. The reduction of MDSCs correlated
with high plasma viral loads and low CD4+ T cell counts, suggesting that depletion of BM
MDSCs was associated with SIV/AIDS disease progression. Of note, in SHIVSF162P4-infected
macaques, which naturally control viral replication within a few months of infection, the fre-
quency of MDSCs in the bone marrow was unchanged. To investigate the mechanisms by
which BM MDSCs were reduced during chronic SIV infection, we tested several hypotheses:
depletion due to viral infection, alterations in MDSC trafficking, and/or poor MDSC replenish-
ment. We found that the possible mobilization of MDSCs from BM to peripheral tissues and
the slow self-replenishment of MDSCs in the BM, along with the viral infection-induced deple-
tion, all contribute to the observed BM MDSC reduction. We first demonstrate MDSC SIV
infection in vivo. Correlation between BM CD14+MDSC reduction and CD8+ T cell activation
in tissues is consistent with decreased immune suppression by MDSCs. Thus, depletion of
BM MDSCs may contribute to the pathologic immune activation during chronic SIV infection
and by extension HIV infection.
Author summary
Both cancer and infectious diseases including HIV/AIDS lead to the accumulation of
myeloid-derived suppressor cells (MDSCs), which can effectively suppress anti-tumor
and anti-viral T cell responses to dampen protective immunity. Using a macaque model,
we found unexpectedly that the MDSCs in bone marrow (BM) decreased after chronic
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simian immunodeficiency virus (SIV) infection compared with healthy controls. This was
in sharp contrast to the general increase of MDSCs observed in BM during cancer and
other infectious/inflammatory diseases, and also contrary to the MDSC expansion in
HIV/SIV-infected PBMCs. We further demonstrated that the loss of MDSCs in the bone
marrow was associated with the progression to AIDS disease. Investigating the mecha-
nisms by which the MDSCs were decreased in the SIV-infected bone marrow, we found
that the possible mobilization of MDSCs from bone marrow to peripheral tissues and the
slow self-replenishment of MDSCs in the bone marrow, along with the viral infection-
induced depletion, all contribute to the observed bone marrow MDSC reduction. Indeed,
this is the first demonstration to our knowledge of SIV infection of MDSCs in vivo.
Because of the suppressive nature of the MDSCs, the CD8+ T cells might not be effective
in killing the virally infected MDSCs. It is tempting to speculate that MDSCs may consti-
tute latent reservoirs. Overall, our data showed that MDSCs act as a double-edged sword
in HIV/SIV-infection, and the decrease of MDSCs in bone marrow after SIV infection
could serve as an indicator of immune regulatory exhaustion and also contribute to the
observed immune hyperactivation seen in HIV/AIDS.
Introduction
Myeloid-derived Suppressor Cells (MDSCs) are immature cells of myeloid origin, frequently
found in tumor microenvironments and in the blood of cancer patients [1–3]. Bone marrow
(BM) is the reservoir for MDSCs. Under homeostatic conditions, there is a delicate balance
between the immature MDSCs and matured myeloid cells in the BM. Normally, only matured
myeloid cells are released from the BM to peripheral blood and tissues. MDSCs maintain a rel-
atively low level in peripheral blood and tissues, and do not expand under normal physiologi-
cal conditions. In healthy mice, Gr-1+CD11b+ MDSCs constitute 20–30% of the total cells in
BM, 2–4% of peripheral blood cells, 2–4% of spleen cells, 2–5% of liver cells, and <1% of
lymph node cells [2, 4, 5]. Cancer leads to MDSC expansion in tumors, and lymphoid tissues,
reaching up to 50% of the total cells in lymph nodes, and bone marrow of tumor-bearing mice
[6], and patients with pancreatic cancers [7]. MDSCs were implicated in the suppression of dif-
ferent immune cells including T cells and NK cells[8, 9]. Several suppressive mechanisms of
MDSCs have been described including: (1) direct suppressive activities through the production
of arginase1(ARG1), indoleamine 2,3-dioxygenase (IDO), reactive oxygen species(ROS),
inducible nitric oxide synthase (iNOS), TGF-β, IL-10, and PD-L1 expression; (2) the expan-
sion of regulatory T cells (Treg)[10–16]. In humans, MDSCs are a heterogeneous population
without specific markers. Two main subtypes, monocytic, and polymorphonuclear (or granu-
locytic)-MDSCs, have been described in humans based on their phenotype and functions.
Monocytic(M)-MDSCs were defined as HLA-DR-/lowCD33+CD11b+CD14+ (hereafter referred
to as CD14+ MDSC), while polymorphonuclear (PMN, also called granulocytic)-MDSCs were
defined as Lin-HLA-DR-/lowCD33+CD11b+CD15+(hereafter referred to as Lin-CD15+MDSCs)
[8, 17–19]. Recently a new subset called early-stage MDSCs (eMDSCs) was added with pheno-
typical makers as Lin-(including CD3, CD14, CD15, CD19, CD56) HLA-DR-/lowCD33+ [18].
In some of the studies, cancer leads to the expansion of both PMN and M-MDSCs, with
PMN-MDSC as the predominant subset [19, 20]. Both subsets demonstrated a suppressive
effect in vitro. However, M-MDSCs have been identified as the more suppressive subset in
vivo, and the loss of PMN-MDSC has not altered tumor incidence [21]. MDSC expansion also
occurs in non-cancer settings [12, 22–29]. For example, in late septic mice: Gr-1+CD11b+
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MDSCs were increased dramatically with up to 40% of the total cells in spleen (vs. 2–4% in
normal spleen), 90% of the total cells in BM (vs 20–30% in normal BM), and 3–4% of the total
cells in lymph nodes (vs.<1% in normal lymph nodes)[30, 31].
MDSCs are significantly increased in peripheral blood of HIV/simian immunodeficiency
virus (SIV)-infected individuals/macaques [12, 22, 23]. Similar to their roles in the tumor micro-
environment, MDSCs in HIV/SIV-infections effectively suppress the function of T cells, and thus
play an important role in dampening protective immunity [8, 12, 22, 23]. However, there are no
details known regarding MDSC distribution and their roles in different tissues during HIV infec-
tion in humans. Because SIV-macaque models recapitulate the pathogenesis of HIV infections,
they are considered one of the best animal models for AIDS research. In this study, we investi-
gated MDSC tissue distribution, and possible MDSC roles during SIV infection using single sus-
pension cells obtained from eight different anatomic compartments of SIVmac251-infected
rhesus macaques. Surprisingly we found that MDSCs in the BM were paradoxically decreased in
chronic SIV infection (dropping from 22% to 8%). Furthermore, the reduction of BM MDSC
correlated with high plasma viral loads (VL), low CD4+ T cell preservation, and general high
CD8+ T cell immune activation. We found that an increase in the trafficking and continuous
mobilization of the MDSCs from bone marrow to peripheral blood and tissues might be one
cause, along with poor replenishment of MDSCs in BM. A second cause is our discovery of viral
infection of MDSCs that may further exacerbate the decrease of MDSCs. Taken together, our
data suggest that the decrease in BM MDSC may contribute to immune deficiency and immune
activation in macaques chronically infected with SIV.
Results
High frequencies of MDSCs in BM, liver, and PBMC, but not in lymph
nodes (LN)
Because information on tissue distribution of the MDSCs in normal and HIV-1 infected
humans is limited, we investigated the distribution of MDSCs in eight different tissue com-
partments of SIVmac251-infected Indian rhesus macaques. Single cell suspensions from tis-
sues of 12 SIVmac251 chronically infected macaques (14 months post-infection) were
obtained and subjected to flow cytometric analysis of MDSCs [23]. We examined the frequen-
cies of two MDSC subsets, which were both HLA-DR-/lowCD33+CD11b+ and either Lin-/low
CD15+(Lin-CD15+MDSC) or CD14+ (CD14+ MDSC) (Fig 1A) [19, 23, 32–34]. These animals
showed a typical dynamic of the plasma VL after pathogenic SIVmac251 infection with peak
VL at Week 2 followed by persistent set-point VL from Week 6 to the end study at week 60
(Fig 1B). Among the eight compartments from the chronically infected macaques, interest-
ingly, high frequencies of both types of MDSCs were found in BM (4.8% and 3.1% for
Lin-CD15+ and CD14+ MDSCs, respectively, P<0.05 for BM vs. all the other compartments
except liver and PBMC in both types of MDSCs after Dunn’s multiple comparison tests), liver
(0.8% and 2.0% for Lin-CD15+ and CD14+ MDSCs, P<0.05 for liver vs. axillary LN, mesen-
teric LN, and colon lamina propria (LP) in both types of MDSCs after Dunn’s multiple com-
parison tests), and PBMC (0.3% and 1.1% for Lin- CD15+ and CD14+ MDSCs, P<0.05 for
liver vs. axillary LN, mesenteric LN, and colon LP in both types of MDSCs after Dunn’s multi-
ple comparison tests) with intermediate levels of MDSCs in spleen and gut; but very few of
either subset in the LNs (Fig 1C and 1D). For both subsets of MDSCs, when we analyzed the
associations among different tissues, we could not find any correlations between any pairs of
compartments (S2 and S3 Tables), suggesting compartmentalization. For example, the animal
with the highest CD14+MDSCs in the BM (8%) only had 0.2% of CD14+MDSCs in the PBMC.
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In addition to MDSCs, we also measured viral-specific CD8+ T cell responses by gag CM9
peptide-Mamu A01 Dextramer as well as the total proliferating CD8+ T cells by Ki67 in these
animals, because both can be affected by MDSCs. Because all the animals were Mamu A01+,
SIVgag-CM9 Dextramer+ cell frequencies were measured to represent viral-specific CD8+ T cell
responses[35]. As shown in Fig 1E, SIVgag-CM9 Dextramer+ cell frequencies in PBMC was
1.7%, much lower than in the remaining tissues, which ranged from 3% to 5% of total CD8+ T
cells (P<0.05 for PBMC vs. axillary LN, mesenteric LN, spleen and BM after Dunn’s multiple
comparison tests). However, the frequencies of CM9 Dextramer+ in total CD8+ T cells from dif-
ferent tissues were highly correlated with each other (S4 Table), suggesting the equilibration of
antigen-specific T cell responses among different tissue compartments. The proportion of total
CD8+ T cells that expressed Ki67 ranged from 35 to 54%, without significant differences among
the compartments (Fig 1F). We found that the frequencies of Ki67+ within the total CD8+ T
cells from different tissues were also associated with each other (S5 Table). Overall, the tissue
distribution patterns of viral-specific CM9 Dextramer+ and total Ki67+ CD8+ T cells were differ-
ent from those of MDSCs in the same SIV-infected macaques. It is of note that the MDSCs did
not accumulate in the lymphoid tissues of the SIV-infected macaques during the chronic stage,
which marked a sharp contrast to cancer and some infectious diseases[36].
MDSCs in bone marrow were decreased after SIV infection, and
correlated with markers of SIV disease progression
Due to the tissue distribution shown in Fig 1, we then focused on the MDSCs in BM, liver and
PBMC. One important question was whether the frequencies of the MDSC subsets were
altered during chronic SIV infections. To make the comparisons, we measured the frequencies
of MDSCs among PBMCs (from two cohorts, n = 40 and 28), liver (from two cohorts, n = 4
and 4) and BM (from two cohorts, n = 28 and 12) from naïve macaques. Using a similar gating
strategy (Fig 2A), we found that while naïve animals had a low frequency of MDSCs in PBMCs
(0.09±0.02% and 0.20±0.04% for CD14+ and Lin-CD15+MDSC), PBMC MDSC frequencies
were elevated after SIV infection (1.15±0.14% and 0.27±0.08% for CD14+ and Lin-CD15+
MDSC in PBMCs) (Fig 2B). This is consistent with the results from previous studies showing
an expansion of MDSCs in the PBMCs after HIV-1/SIV infection[12, 22, 23]. Though both
subsets of MDSCs were more prevalent, we observed a more dramatic increase of the CD14+
MDSC subset than the Lin-CD15+MDSC subset: 13-fold increase of CD14+ MDSC compared
with almost no change of Lin-CD15+MDSC after SIV chronic infections. Due to the small
number of naïve liver samples that were available, we could not reach any conclusions as to
effect of SIV infection on liver MDSCs (Fig 2C). Surprisingly, we found that the total number
of MDSCs (defined as the sum of CD14+ MDSC and Lin-CD15+MDSC) in BM was paradoxi-
cally decreased 14 months after SIVmac251 infection (Fig 2D). Specifically, there was roughly
a 4.7-fold reduction in the CD14+ MDSC subset (from 14.5±1.3% in naïve animals vs. 3.1
±0.07% in SIV-infected ones, P<0.0001), and a 1.6-fold reduction in the Lin-CD15+MDSC
subset (7.7±0.6 vs. 4.8±0.7% respectively, P = 0.005) (Fig 2D). This pattern of the MDSC
Fig 1. High frequencies of MDSCs were found in bone marrow, liver, and PBMC, but very few in the LNs of the chronically SIV-
infected macaques. (A) The gating strategy of CD14+MDSCs and Lin- CD15+MDSCs from the SIV-infected bone marrow. The same gating
strategy was used for other compartments. (B) The kinetics of plasma VLs in the 12 SIVmac251-infected macaques showed persistent viral
infection (mean±SEM). Single suspension cells from eight compartments of 12 SIVmac251 chronically (14 months-) infected Indian rhesus
macaques were used to measure the frequencies of CD14+ MDSCs (C), Lin- CD15+MDSCs (D), gag-specific CM9 Dextramer+ (E), and Ki67+
(F) in CD8+ T cells. In C-D, P<0.05 for bone marrow vs. all the other compartments except liver and PBMC; P<0.05 for liver vs. axillary LN,
mesenteric LN, and colon LP; P<0.05 for PBMC vs. axillary LN, mesenteric LN, and colon LP in both types of MDSCs after Dunn’s multiple
comparison tests. In E, P<0.05 for PBMC vs. axillary LN, mesenteric LN, spleen and bone marrow after Dunn’s multiple comparison tests.
https://doi.org/10.1371/journal.ppat.1006395.g001
Myeloid-derived suppressor cell reduction in bone marrow contributes to HIV pathogenesis
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006395 May 12, 2017 5 / 28
Myeloid-derived suppressor cell reduction in bone marrow contributes to HIV pathogenesis
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006395 May 12, 2017 6 / 28
distribution in the SIV-infected animals was markedly different from that in tumor-bear-
ing mice, where BM MDSCs are elevated [4, 5]. Furthermore, we found two subpopula-
tions of CD14+ MDSCs in the BM: CD14high and CD14intermediate MDSCs (S1 Fig). Most
CD14intermediate population were HLA-DR-/low cells in SIV-infected and naïve BM. This
HLA-DR-/low CD14intermediate population was prominent in the naive animals, but lower in
the SIV-infected animals (S1 Fig). Compared to naïve BM, the CD14+ population was also
decreased in the SIV-infected BM (S2 Fig).
Because MDSCs, especially Lin-CD15+ subset, are sensitive to cryopreservation [37], and
we used frozen cells throughout the whole study, there is a possibility that SIV infection might
differentially affect the loss of SIV-infected MDSCs compared to naïve cells. To test this, we
compared the frequencies of MDSC subsets in paired specimens of fresh vs frozen BM and
PBMC obtained from the SIV-infected (BM: n = 6; PBMC: n = 7) and naïve animals (BM:
n = 12; PBMC: n = 5). The PBMC and BM samples from the SIV-infected and naïve animals
were isolated, and divided into two aliquots, one was immediately stained and analyzed by
flow-cytometry, the other was cryopreserved in liquid N2 and thawed for testing 4–5 months
later. After cryopreservation and thawing, 70–80% of CD14+MDSCs were preserved in the
naïve and SIV-infected BM samples; 65% of CD14+MDSCs were also preserved in the SIV-
infected PBMC samples (S3 Fig). Consistent with the previous study [37], only 20% of
Lin-CD15+ MDSCs were preserved in the naïve and SIV-infected BM samples (S3 Fig), sug-
gesting Lin-CD15+MDSC subset was more sensitive to cryopreservation. Importantly, we did
not observe any significant difference of MDSC subset loss for the BM samples between the
SIV-infected and naïve animals. Thus, SIV infection does not differentially affect the loss of
MDSC subsets from BM compared to naïve ones.
We then asked whether SIV VLs correlated with the reduction of BM MDSCs. Among the 12
SIV-infected macaques, five of them controlled SIV replication, with plasma VLs below 5,000
copies/ml. The remaining 7 animals did not control SIV replication, with VLs>5,000 copies/ml.
We found that the controllers maintained high BM MDSC frequencies, whereas the non-control-
lers had reduced BM MDSC frequencies (Fig 3A). This change was not found in the PBMC or
the liver, although the liver showed the same trend (Fig 3A). Indeed, the frequencies of both sub-
sets of MDSCs in BM inversely correlated with VL (Fig 3B). In the BM of chronically SIV-infected
macaques, the frequencies of CD14intermediate MDSCs inversely correlated with plasma viral loads
better than that of CD14high MDSCs (S4 Fig). We also found that both subsets of MDSCs in the
BM positively correlated with absolute blood CD4 count ratio (necropsy end-point CD4+ T cell
count/pre-challenge CD4+ T cell count ratio) (Fig 3B). The association between BM MDSC deple-
tion and high VLs and low CD4+ T cell counts suggests that MDSC depletion may contribute to
disease progression, or at least serve as marker of disease progression.
SHIVSF162P4-infected macaques, which had undetectable plasma VL 11
months post-infection, maintained their normal frequency of MDSCs in
bone marrow
The data suggested that exposure to pathogenic SIV infection decreased MDSC frequencies in
the BM. We then asked if similar changes occurred in Indian rhesus macaques infected with
Fig 2. CD14+ and Lin-CD15+MDSCs were decreased in BM and increased in peripheral blood during chronic SIV infection. (A) The
gating strategy of CD14+MDSCs and Lin-CD15+ MDSCs from the naïve bone marrow. (B-D) The MDSC frequencies of the naïve macaques
in the PBMCs (68 naïve animals, the purple and orange squares denote the PBMC samples from two different cohorts of naïve animals.),
liver (8 animals; purple and blue squares represent livers from 2 different cohorts of naïve animals) and bone marrow (40 naïve animals, the
purple and orange squares denote the bone marrow samples from two different cohorts of naïve animals.) were measured and compared
with those of the SIV-infected macaques (n = 12 for each compartments). Mann-Whitney was used for the comparisons.
https://doi.org/10.1371/journal.ppat.1006395.g002
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SHIVSF162P4. All the SHIVSF162P4-infected animals demonstrated high peak VLs during the
first 6 weeks of infection, followed by viral control 3 to 4 months post-infection (Fig 4A). At 11
months post-infection, when VL was near or below the detection limit, there was no change in
BM MDSC frequency (Fig 4B). In those samples, there was no change in either the Lin-CD15+
MDSC or CD14+ MDSC (Fig 4B). The same was also true for MDSCs in the 11-month post
SHIV-exposed PBMC and liver (Fig 4C and 4D). Thus, infection with SHIV without persistent
viremia did not affect MDSC frequency in BM, but infection with pathogenic SIV depleted
BM MDSC.
Mechanisms of MDSC reduction in the bone marrow of macaques
chronically infected with SIV
We next investigated what caused the reduction of MDSCs especially in the CD14+ subset in
the BM of the SIV-infected macaques. We proposed three hypotheses: depletion due to viral
infection, increase in MDSC mobilization/trafficking out of BM, and poor MDSC replenish-
ment from hematopoietic stem cells.
MDSC infection by SIV in vivo. The SHIV infection data suggest that only pathogenic
viruses can decrease MDSC frequency. Thus, the MDSC decrease may be due in part to direct
infection with SIV and virus-mediated cell death. In fact, HIV-1 infects MDSCs in vitro [22].
We asked whether MDSCs were infected by SIV in vivo, which had not been described previ-
ously. Using FACS, we purified MDSCs from the PBMCs or spleens of the chronically SIV-
infected macaques (Fig 5A, purity>95%). The isolated RNAs from purified MDSCs were then
subjected to qPCR to detect the expression levels of SIV gag, CD3 and CD4, while purified
CD4+ T cells were used as positive controls. We found that all the MDSC samples were nega-
tive for CD3 mRNA, suggesting no T cell contamination for the MDSC subsets. Most of the
MDSC samples (4 of 6) were positive for SIV gag and CD4, indicating infection of the MDSCs
by SIVmac251. Importantly, the ratio of SIVgag to CD4 was much higher in the MDSC popu-
lation than the CD4+ T cell population, further confirming that the virus detected could not be
due to contaminating CD4+ T cells (Fig 5B, S5 Fig). Concordant with that, we also found that
the SIVgag expression level is comparable between CD4+ T cells and MDSCs (ratio around 1),
whereas the CD4 expression level was much lower in MDSCs than in the CD4+ T cell subset
(Fig 5C, S6 Fig), further supporting the conclusion that MDSC-associated viral RNA could not
be due to CD4+ T cell contamination. Since the SIVgag assay cannot distinguish the genomic
RNA in virions or infected cells from the SIVgag mRNA, we performed real-time RT-PCR
assays to detect the spliced viral mRNAs that are produced only in infected cells. Spliced viral
mRNAs can thus act as a marker of active virus replication. While all the T cell samples were
positive for spliced viral mRNA, out of the four MDSC samples that were positive for SIVgag,
we found that 2 of them were also positive for spliced viral mRNA (S7 Fig). Given the impor-
tance of this finding, we tested additional animals in an independent experiment to confirm
the conclusion of productive infection of MDSCs. We performed another MDSC sorting using
six SIVmac251-infected BM samples to detect the spliced SIV mRNA. The sorted CD4+T cells
Fig 3. After chronic SIV-infection, non-controller (log VL>3.7) had lower MDSC in the bone marrow than
those of the controllers (log VL<3.7). (A) Among the 12 SIV-infected macaques, 5 of them were controllers
with plasma viral loads below 5,000 copies/ml, while the remainder of them (n = 7) were non-controllers with viral
loads greater than 5,000 copies/ml. MDSC (both CD14+ MDSC and Lin-CD15+ MDSC subsets) in the bone
marrow of the controllers maintained relatively higher levels compared with those of the non-controllers. Mann-
Whitney was used for the comparisons. (B) The MDSCs in the bone marrow inversely correlated with the
plasma VLs, and positively correlated with absolute CD4 count ratio (Necropsy CD4+ T cell count/pre-challenge
CD4+ T cell count). Spearman analysis was used for correlations. Total MDSC was the sum of CD14+MDSC
and Lin-CD15+ MDSC subsets.
https://doi.org/10.1371/journal.ppat.1006395.g003
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Fig 4. The MDSCs in the bone marrow of macaques after SHIV-infection showed that persistent viral exposure was needed
for the reduction of the MDSCs in the bone marrow. (A) Plasma VLs after SHIVSF162P4-infected macaques (n = 12) (mean
±SEM). Total MDSCs CD14+ MDSCs, and Lin-CD15+ MDSCs in bone marrow (B), and PBMC (C) of the macaques before infection,
and 11 months post-SHIV infection were compared. Pre-infection samples of PBMC and BM were the matched controls for the
11-month post-infection samples. Wilcoxon tests were used for comparisons. (D) The MDSCs in the liver of the 11 months post-SHIV
infections were compared with naïve and normal controls, Man-Whitney were used for comparisons.
https://doi.org/10.1371/journal.ppat.1006395.g004
Myeloid-derived suppressor cell reduction in bone marrow contributes to HIV pathogenesis
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006395 May 12, 2017 10 / 28
were 10-fold serially diluted to generate a titration curve so that the detection limit of spliced
SIV /CD3 mRNA was from 90 to 900000 CD4+T cells. Four sorted MDSC samples were nega-
tive for CD3 mRNA, and three out of these four were positive for spliced SIV mRNA (S7 Fig).
Overall, these two independent experiments (S7 Fig) demonstrated that the spliced SIV
mRNA were present in the MDSC (5 out of 8 CD3 negative) samples, indicating productive
infection rather than BM-phagocytosis of infected cells.
Fig 5. qPCR analysis of SIV-gag showed that the MDSCs were infected by SIVmac251 in vivo. (A) Sorting strategies for MDSCs
and CD4+T cells from the PBMCs of SIV-infected macaques. (B) The ratio of mRNA of SIVgag vs mRNA of CD4 in CD4+T cells and
MDSCs showed that MDSCs had a higher SIVgag/CD4 ratio. (C) The ratio of SIVgag expression level in MDSCs vs SIV gag expression
level in CD4+T cells showed that MDSCs and CD4+T cells had a comparable level of SIVgag expression. (D) In another independent
experiment, MDSCs and CD4+ T cells from the PBMCs of the SIV-infected animals were sorted as in A. For the sorted CD4+ T cells, the
samples were serially diluted (10–fold) before the RNA isolation. After RNA isolation and cDNA synthesis, each of the CD4+ T and MDSC
samples was subjected to qPCR analysis for SIVgag, CD3, CD4, and GAPDH using the same amounts of cDNA. The detection limit for
Gag and CD4 is 50 copies/well (shown by the dashed horizontal lines). If the gag copy number was lower than 50, 50 was assigned to the
tested sample. Black dots in D are CD4+ T cells as positive control titration curve, while red squares are the MDSCs plotted on the same
scale, and red numbers are the copy numbers of SIVgag in MDSCs. The number of cell equivalents used in each assay was shown in the
horizontal axis.
https://doi.org/10.1371/journal.ppat.1006395.g005
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To further confirm that SIV infects MDSC in-vivo, we sorted MDSCs and CD4+ T cells
from the blood of 6 additional SIV-infected animals. We isolated RNA from MDSC and CD4+
T cell samples and performed 10-fold serial dilutions of CD4+ T cells (up to 5 dilutions) to gen-
erate titration curves, which were linear on a log-log scale (black dots in Fig 5D). After RNA
isolation and cDNA synthesis, each of the CD4+ T and MDSC samples was subjected to qPCR
analysis for detection of SIVgag, CD3, CD4, and GAPDH using the same amounts of cDNAs
(red symbols superimposed on titration curves represent MDSCs from the same animal on the
same scale). Out of these 6 animals, we failed to isolate RNA from one sample due to a low
number of MDSC sorted. Out of the five samples from which we have successfully isolated
RNA, we could not detect SIVgag from one sorted MDSC sample (the detection limitation
for Gag is 50 copies/well). Among the four MDSC samples scoring positive for SIVgag, we
detected CD3 mRNA from two of them (NHP-a and -b) (Fig 5D), indicating possible contami-
nation or phagocytosis of the T cells as suggested by another study[38]. However, SIV gag was
detected in the two remaining SIVgag-positive samples (NHP-c and–d), that were negative for
CD3 mRNA, indicating infection of MDSC. The sensitivity to detect T cell contamination in
these two animals was 27 and 80 CD4+ T cells (S7 Fig). Note that the housekeeping gene
GAPDH was expressed at the same level per cell in the MDSCs (red) as in the CD4+ T cells
(black dots) (S7 Fig).
We also assessed SIVgag p27 expression in BM cells of SIVmac251 chronically infected BM
by Immunocytochemistry. In all 6 SIV+ animals a variable number of Lin-CD15+ and CD14+
MDSCs were positive for SIV P27. Thus, both subsets of MDSC are infected by SIVmac251 in-
vivo (Fig 6). Results from one representative experiment are shown (Fig 6A). The summary of
three independent experiments demonstrated that the P27+% in both subsets of MDSCs from
the SIV-infected bone marrow was significantly higher than in naïve animals (Fig 6B, S8 Fig).
Note that the MDSCs from SIV-infected animals not only had substantially more events in the
positive gate, but also had brighter staining indicating real infection. Thus, SIV infects both
subsets of MDSCs in vivo and this could directly contribute to their depletion from the BM of
infected animals.
MDSC trafficking from BM to blood. We then explored the MDSC mobilization/traf-
ficking hypothesis, in which MDSCs moved from BM to blood and peripheral tissues with
an accelerated rate after SIV-infection compared with those of the uninfected controls.
To test this hypothesis, we performed in vitro chemotaxis assays to measure the movement
of BM single-cell suspensions towards the plasma of pre- and post-infected animals. We
observed that the MDSC chemotaxis index toward the plasma of the post-infected samples was
significantly higher than those of the pre-infected plasma (Fig 7A). However, the chemotaxis
indexes of total cells and of T cells did not change after SIV-infection (Fig 7A). These data sug-
gested a preferential trafficking of MDSCs, but not T cells or total cells, from BM to blood after
SIV-infection. We then investigated whether the MDSC chemotaxis index was associated with
the frequencies of MDSC in the SIV-infected PBMC. We observed trends of positive correla-
tions between the MDSC chemotaxis index from the SIV-infected plasma and the frequencies
of CD14+, CD15+Lin-, and total MDSCs in SIV-infected PBMCs, suggesting the important
role of MDSC trafficking from bone marrow to blood during SIV infection (Fig 7B).
We then sought to characterize the chemokine(s) responsible for the trafficking of MDSCs.
During cancer and HIV infection, the balance between MDSCs in BM and peripheral tissues is
interrupted due to the massive cytokine/chemokine storm that characterizes these conditions.
CCL2 (also known as MCP-1) is a key chemokine involved in MDSC trafficking. In tumor-
bearing mice, the CCR2-receptor is highly expressed by most MDSC subsets, and CCL2 alone
is sufficient to induce migration of MDSCs [39]. It has been shown that CCL2 is up-regulated
upon HIV infection [40]. Based on this, we proposed that changes in CCL2 levels might be
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responsible for the trafficking of the MDSCs from BM to the periphery in the SIV-infected
macaques. Indeed, we found that the expression level of CCL2 in the plasma of SIV chronically
infected macaques was significantly greater than that of the naïve control samples (Fig 7C).
Furthermore, it was also positively correlated with the CD14+ MDSC subset (Fig 7C), but not
the Lin-CD15+MDSC (Spearman P = 0.9) in the PBMCs, suggesting that CCL2 might be
responsible for the accumulation of the CD14+ MDSC in the peripheral blood. However, we
did not find a correlation between CCL2 and the MDSC chemotaxis index measured in in
vitro chemotaxis assays, suggesting that other chemokines, besides CCL2, in the SIV-infected
plasma, play roles in determining the migration of MDSCs from BM to blood (Fig 7C).
MDSC replenishment from hematopoietic stem cells. Another important factor that
could affect the frequency of the MDSCs in the bone marrow is rate of MDSC replenishment.
Due to the infection of the BM accessory cells, impaired stromal function and alteration of the
hematopoietic growth factor network was frequently observed in the BM of patients with
HIV-1 infection[41–43]. These events directly lead to disruption of normal hematopoiesis in
Fig 6. Flow cytometric detection of gag-P27+ MDSCs and CD4+T cells in the bone marrow of SIV-infected or naive animals. (A) One
representative P27 staining from one experiment with 7 naïve and 3 SIV-infected animals (B) Summary of three independent experiments with total 6 SIV-
infected, and 12 naïve animals. The SIV-infected and naïve animals from the same experiment were shown in same color. Each data point represents one
individual animal. The Man-Whitney tests were used for comparisons.
https://doi.org/10.1371/journal.ppat.1006395.g006
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the BM[44, 45]. Our hypothesis was that chronic SIVmac251 infection might impair the
proliferation of MDSCs in the BM. We measured the cell proliferation marker Ki67 to assess
the proliferative replenishment rate of MDSCs in the BM. Indeed, proliferation of both
CD14+ and Lin-CD15+MDSCs in BM was lower in SIV-infected macaques than in naïve
controls (Fig 8A–8C). In the SHIV-infected macaques, which spontaneously controlled
their viral replication several months after the infection, we found that the proliferation of
the CD14+ and Lin-CD15+ MDSCs in the bone marrow 11 months post-infection were also
significantly lower than those of the uninfected controls (Fig 8A–8C). Even through the
proliferation of both subsets of MDSCs were decreased in SHIV chronically infected BM,
the frequency of both subsets were maintained at pre-infection levels (Fig 4B). Interestingly,
in both SIV-and SHIV-infected animals, we observed a bimodal Ki67-positive population
Fig 7. Preferential trafficking of MDSCs from BM to peripheral blood during chronic SIV infection measured by in vitro chemotaxis assays. (A)
Chemotaxis index of MDSCs, T cells and total cells were compared before and after SIV infections. Wilcoxon tests were used for comparisons. (B)
Correlation trends were observed between MDSC chemotaxis index and CD14+ or Lin- CD15+ or total MDSCs in the PBMCs after chronic SIV infection.
Spearman analysis was used for correlations. (C) Plasma CCL2 level was higher in the SIV-infected macaques than in naïve ones, and correlated with
CD14+ MDSC in the PBMCs, but did not correlate with the MDSC chemotaxis index. Man-Whitney tests were used for comparisons, and Spearman
analysis was used for correlations.
https://doi.org/10.1371/journal.ppat.1006395.g007
Myeloid-derived suppressor cell reduction in bone marrow contributes to HIV pathogenesis
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006395 May 12, 2017 14 / 28
Ki67high subsets in CD14+ and Lin-CD15+MDSCs, which were almost absent from those of
the uninfected controls (Fig 8A).
Thus, the slow self-replenishment of BM MDSCs probably exacerbated the decrease of
MDSCs when they were killed by virus, or migrated out of the BM.
MDSC reduction in bone marrow was associated with increased T cell
immune activation
We then sought to clarify the consequences of the MDSC reduction in the BM. Because the
main known function of MDSCs is to limit excessive T cell proliferation, and thus control tis-
sue damage, we proposed that BM MDSC reduction would be associated with T cell activation,
especially among CD8+ T cells. We measured the frequencies of Ki67+ CD8+ T cells in the
Fig 8. MDSC proliferation was decreased in the bone marrow of SIV-infected macaques. (A) Representative Ki67+% of the gated CD14+ and Lin-
CD15+MDSCs in the bone marrow from naïve, SIV- or SHIV-infected macaques. (B, C) Ki67+% of the gated CD14+ and Lin- CD15+MDSCs in the bone
marrow was lower in the SIV-infected macaques than in the naïve, or SHIV-infected animals. Man-Whitney were used for comparisons between the naïve
and SIV- or SHIV-infected macaques. The black and orange dots denote the bone marrow samples from two different cohorts of naïve animals.
https://doi.org/10.1371/journal.ppat.1006395.g008
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tissues of the SIV-infected macaques, and then performed correlation analyses between fre-
quency of BM CD14+ / Lin-CD15+MDSCs and the frequencies of Ki67+ CD8+ T cells in these
compartments. We found that the frequency of BM CD14+ MDSCs inversely correlated with
the frequency of Ki67+CD8+ T cells in BM, PBMC, spleen, ALN, but not MLN, liver, ileum LP
and colonic LP (although MLN and colonic LP showed nearly significant trends) (Fig 9A–9H);
whereas Lin-CD15+ MDSC did not correlate with the frequency of Ki67+CD8+ T cells in any
of the compartments except PBMC (S9 Fig). Overall, the association of BM CD14+ MDSC fre-
quency with CD8+ T cell immune activation, plasma vRNA levels, and CD4+ T cell loss sug-
gests that the reduction in BM CD14+ MDSC contributes to the pathogenesis of the HIV/SIV
infections.
Discussion
Cancer and some infectious/inflammatory diseases lead to MDSC accumulation in peripheral
blood and multiple tissue compartments, including BM[1–6]. A higher frequency of MDSCs
in a cancer setting is usually associated with a poor prognosis[7, 34]. In this study, we found
unexpectedly that BM MDSCs paradoxically decreased after chronic SIV infection compared
with healthy controls. This was in sharp contrast to the general increase of MDSCs observed in
BM during cancer and other infectious/inflammatory diseases, and also contrary to the MDSC
expansion in HIV/SIV-infected PBMCs [12, 22, 23]. We further demonstrated that even
though the changes were among both CD14+ and Lin-CD15+MDSC subsets in BM, and both
subsets correlated with high plasma vRNA level and CD4+ T cell loss, it was only the reduction
of CD14+ MDSC that correlated with the high levels of CD8+ T cell activation. These changes
suggest that the loss of BM MDSCs, especially the CD14+ subset, was associated with the pro-
gression to HIV/AIDS disease. We then investigated the alteration of MDSCs in the BM of a
less pathogenic SHIV-macaque model, in which the animals had moderate plasma vRNA lev-
els at the first 6 weeks of infection, but spontaneously controlled the viral replication after sev-
eral months. These animals had no signs of immune activation, and did not develop AIDS-
related disease. Indeed, in these animals, we found that both subsets of BM MDSCs were
unchanged 11 months post-infection. This further supported the association of MDSC
decrease in BM with HIV/AIDS disease progression.
During HIV/SIV infection, MDSCs are thought to contribute to immune-pathogenesis by
dampening protective immunity through the direct inhibition of T cell function, especially the
viral-specific CD8+ T cell responses, and thus are deleterious[12, 22, 23]. However, our data
suggest more complex and somehow paradoxical roles of MDSCs in HIV/SIV infections.
MDSCs suppress anti-viral specific immune responses, which hindered the control of HIV
replication [22, 23]. However, MDSCs also have the capacity to antagonize immune activation,
which plays a key role in driving viral transmission and replication and many of the disease
processes associated with AIDS [46–48]. Consistent with this, the CD14+ MDSCs in the BM
inversely correlated with immune activation (Ki67+CD8+T cells) of multiple tissue compart-
ments, suggesting that depletion of BM MDSCs contributes to the immune activation in
chronically infected macaques. During late HIV infection, the balance of immune suppression
and immune activation tips in favor of the latter due to factors such as gut microbe transloca-
tions[49, 50]. It has been proposed that MDSCs are responsible for restoring the balance
through various mechanisms, including arginase-1, inducible nitric oxide synthase, reactive
oxygen species, and induction of regulatory T cells [46, 51–53]. However, the reduction of
MDSCs in the BM may impair this function, and contribute to the relentless immune activa-
tion in HIV/SIV chronically infected patients/animals.
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Fig 9. Decreased CD14+ MDSCs in bone marrow were associated with increased immune activation.
The frequency of CD14+ MDSCs was inversely correlated with the Ki67+ CD8+ T cell frequencies in the SIV-
infected bone marrow (A), PBMC (B), spleen (D), Axillary LN (E) and Mesenteric LN (F), but not liver (C),
ileum LP (G) or colon LP (H). (although MLN and colon LP showed strong trends (p = 0.06). Each data point
represents one animal. Spearman analysis was used for correlations.
https://doi.org/10.1371/journal.ppat.1006395.g009
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We are puzzled by the fact that the MDSC reduction in BM correlated with the CD8+ T cell
proliferation in not only the MDSC-high tissues but also the MDSC-low tissues. MDSCs did
not play a direct role in inhibiting CD8+ T cells proliferation in situ in the tissues with low
MDSC frequencies, whereas in the MDSC-high compartments, MDSCs could inhibit the pro-
liferation of CD8+ T cells efficiently. When the CD8+ T cells are equilibrated well among dif-
ferent tissue compartments in the SIV-infected animals, MDSCs suppressing T cell in high-
MDSC tissues could affect the levels of T cells in the MDSC-low tissues indirectly when they
re-equilibrate. MDSCs could play an important role in suppressing immune activation during
HIV infection. Another suppressive mechanism of MDSCs could be the induction of CD4+
Treg cells, which could travel to other MDSC-low compartments, and suppress immune
responses locally[12–14]. Furthermore, MDSCs induced a type 2 polarization of macrophages
in tissues, which were functionally inhibitory [54, 55].
It is worth mentioning that even though both subsets of MDSCs were decreased in the
chronically SIV-infected BM, and associated with markers of disease progression: high plasma
vRNA levels, low CD4+ T cell counts, only loss of CD14+ MDSCs was associated with high
immune activation. Thus CD14+ MDSC and Lin- CD15+ MDSC were not only phenotypically
distinct, but also played different roles in SIV infections. In cancer settings, CD14+ MDSCs
have been shown to be the dominant suppressive populations of MDSCs, and correlated with
cancer incidence, whereas G-MDSC did not correlate with clinical outcomes, even though
both subsets were increased[21]. We also observed more dramatic changes of CD14+ MDSC
subsets in both PBMC and BM after SIV infection. This implied that the two subsets of
MDSCs were under different regulatory mechanisms, and CD14+ MDSCs might be the main
subset that respond to SIV infection, and determine the outcome of SIV infections. However,
as cryopreservation changes the PMN-MDSC (Lin-CD15+) numbers and function[37, 55], and
all the samples used in this study were cryopreserved ones, we should be cautious on the inter-
pretation of data on this subset.
In the present study, to investigate the mechanisms by which the MDSCs were decreased in
the SIV-infected BM, we found that infection by virus, migration out of BM, and/or poor self-
replenishment of MDSCs might all play important roles. With the data we have, it is impossi-
ble to dissect which were more critical. It has been reported that infectious/inactivated HIV, or
gp120/gp41, and tat proteins directly promoted MDSC expansion in an in vitro culture system
using healthy PBMCs [13, 14, 22]. However, we doubt that virus/viral proteins were the key
contributors to the MDSC accumulation in the PBMCs of the infected macaques based on 1)
dramatic increase of M-MDSCs in the PBMCs of HIV-1-infected patients on antiretroviral
therapy with undetectable viremia [14]; 2) no correlations of VLs with MDSC accumulation in
PBMC at different time-points in the same animal[23]; and 3) decreased rather than increased
MDSCs in BM during chronic SIV infection.
Consistent with the finding of CD14+ MDSC susceptibility to HIV-1 infection in vitro [22],
we further demonstrated by three independent mutually corroborative experimental criteria
(gag expression relative to CD3 and CD4 expression, spliced vRNA expression, and p27 pro-
tein production) that both subsets of MDSCs were able to be infected in vivo. In contrast to the
suggestion that the infection of myeloid cells might cause developmental defects in myeloid
cells, and result in accumulation of MDSCs in the in vitro study [22], our data suggest that
infection of MDSCs by SIV in vivo might eventually lead to MDSC depletion directly or indi-
rectly. In the SIV-infected PBMC and BM, the SIVgag+ MDSCs were a small fraction of the
total MDSCs. If infection itself led to MDSC expansion, we would expect a big pool of SIVgag+
MDSCs in the infected animals. We noticed that the relative expression level of SIVgag mRNA
per cell was comparable between CD4+ T cells and MDSCs (Fig 5C), which suggested that
MDSCs could be productively infected by SIV, like their CD4+ T cell counterparts. Productive
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infection was confirmed both by detection of spliced SIV mRNA (S7 Fig), and by staining for
expression of viral gag protein (Fig 6), under conditions in which contamination with T cells
could be ruled out as an explanation. If MDSCs are productively infected with SIV, viral-
induced depletion might play an important role. However, further evidence is needed to con-
firm whether SIV infection leads to MDSC death.
HIV-1 infected patients usually develop hematopoietic dysfunction, which is mainly medi-
ated by the altered production of stromal cell-derived hematopoietic growth factors, infection
of the BM accessory cells, and impaired stromal functionality[41–43, 56]. This abnormality
could lead to defects of MDSC replenishment. Indeed, we found decreased proliferation
(Ki67+%) of both subsets of MDSCs in BM after SIV infection.
The inverse or reciprocal relationship of MDSCs in BM and PBMC, e.g., increased in
PBMC and decreased in BM, promoted us to investigate the possibility of MDSC redistribu-
tion during SIV infection. We compared the chemotactic activities of plasma from the pre-
and post-SIV infection blood using in vitro chemotaxis assays. It turned out that the chemo-
taxis index of MDSCs, but not of T cells or total cells, was increased during chronic SIV infec-
tion. We believe that this could directly lead to MDSC loss in BM, as a consequence of more
MDSCs’ migrating out of the BM. The preferential trafficking of MDSCs towards the post-
infection plasma suggested that certain chemokine(s)/cytokine(s) in the chronic SIV infected
plasma could preferentially pull the MDSCs out of BM. In the attempt to dissect which chemo-
kine(s)/cytokine(s) were responsible, we tested CCL2, known to affect myeloid cell migration.
We found that CCL2 correlated with CD14+ MDSC accumulation in the PBMC, but did not
correlate with MDSC chemotaxis index measured in vitro. Since CCL2 was one of multiple
cytokines/chemokines induced by SIV, other chemokines/cytokines might also play roles in
attracting MDSCs to the circulation. Antibody blocking for CCL2 would be a good way to
assess the role of CCL2 played in chemotaxis. Nevertheless, as MDSCs are such heterogeneous
populations and no single chemokine receptor is truly specific for MDSCs, the net chemoat-
tractant effects of multiple chemokines in the plasma might account for the results of the in
vitro assays.
One caveat was that this was a cross-sectional study of MDSC alteration in BM during the
chronic infection stage. A longitudinal study with multiple time-points during acute and
chronic infection stages will give us a better picture of the MDSC dynamics, and better under-
standing of the roles of MDSCs during SIV infection. We speculate that there is a delicate bal-
ance of immunity and suppression established at the onset of the SIV infection. During the
early stage of the pathogenic SIV infection, it is possible that the MDSC increase/expansion
also occurred in BM, as we have observed in the SHIV-infected macaques, in which MDSCs
initially significantly increased 4 months post-infection (S10 Fig), and then reverted to normal.
In the pathogenic SIV infections, however, the presence of persistent high viral loads, and the
poor self-replenishment by MDSC proliferation due to bone marrow stromal functional
defects could lead to the gradual decrease of MDSCs in BM. Future studies on the kinetics of
MDSCs in the BM of pathogenic SIV infections will clarify this. This depletion of MDSCs
eliminates one of the body’s key mechanisms to limit tissue damage from aberrant immune
activation. Thus, in the setting of acute SIV infection, MDSCs can limit antiviral T cell
responses, whereas in chronic infection, BM MDSC depletion can contribute to the disease
progression. Overall, MDSCs act as a double-edged sword in HIV/SIV-infection, and the
decrease of MDSCs in BM after SIV infection could serve as an indicator of immune regula-
tory exhaustion. Further elucidating the roles of MDSCs in HIV/SIV infection will contribute
to our understanding of the immune-pathogenesis of HIV infections and contribute to the
development of therapeutic approaches for HIV/AIDS.
Myeloid-derived suppressor cell reduction in bone marrow contributes to HIV pathogenesis
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006395 May 12, 2017 19 / 28
Materials and methods
1. Ethics statement
All the adult Indian rhesus macaques (Macaca mulatta) were used with the approval of Institu-
tional Animal Care and Use Committees. The macaques were housed at the NCI Animal Facil-
ity, Bethesda, MD (Protocols No. VB010 and VB011 approved by the NCI IACUC), which is
accredited by the Association for Assessment and Accreditation of Laboratory Animal Care
(AAALAC) International. The housing and the standard practices closely followed the recom-
mendations of the Standards and Guide for the Care and Use of Laboratory Animals of the
United States—National Institutes of Health. All efforts including provision of peri-operative
and post-operative analgesia were made to minimize discomfort of the animals. Details of ani-
mal welfare, including housing, feeding, environmental enrichment, and steps to minimize
suffering, were in accordance with the Guide and the recommendations of the Weatherall
report, ‘‘The use of non-human primates in research”, as approved by the IACUCs. Macaques
were housed in temperature controlled facilities with temperature of 21–26˚C, humidity of
30%– 70%, and a 12 h light/dark cycle. A commercial primate diet and fresh fruit were pro-
vided twice daily with water freely available at all times. Macaques were monitored twice daily
for overall health including activity, food and water intake. The macaques were singly housed
in stainless steel wire-bottomed cages due to the nature of the experiment. Rotating toys, visual
and auditory stimuli, and foraging opportunities were provided daily. The animals were anes-
thetized with approximately 10 mg/kg of ketamine hydrochloride injected intramuscularly for
blood and bone marrow collections. When IACUC defined endpoints were reached, macaques
were humanely euthanized with an overdose of barbiturate in accordance with the recommen-
dations of the most recent American Veterinary Medical Association Panel on Euthanasia.
2. Animals, viral challenge, and viral load (VL) measurements
The 12 simian immunodeficiency viruses (SIV) mac251-infected animals have been described
in our previous studies [23, 57] (S1 Table, cohort 1A). Briefly, the animals were intrarectally
challenged by three serial SIVmac251 viruses at 2-week intervals until they have been infected.
The SIVmac251 viral stock was provided by Nancy Miller of the National Institute of Allergy
and Infectious Diseases (NIAID). Twelve simian–human immunodeficiency virus (SHIV)-
infected macaques were also included in this study (6 males and 6 females; age: 3,3±1.3 years;
weight: 4.6±1.7 kg) (S1 Table, cohort 2A). The animals were intrarectally exposed to 8 serial
SHIVSF162P4 viral challenges with a week of interval (1:35 dilution) until they were infected.
After the viral challenges, SIV/SHIV RNA levels were monitored by Advanced BioScience Lab-
oratories, Inc. The cut-off threshold for viral RNA detection was 50 copies/ml. Blood and tis-
sue samples from naïve macaques were collected and included in the study for comparisons
(S1 Table, cohort 1, 2, 3 and other). Liver tissues from 8 naive (4 adenovirus-exposed, 4 non-
exposed, all SIV/SIHV-negative) macaques were used as normal controls (S1 Table, other).
Other naïve macaques which have been enrolled in this study were described in S1 Table.
Additional SIVmac251 infected bone marrow samples were obtained from California National
Primate Research Center (S1 Table).
3. Preparation of single-cell suspensions from the tissues
Single-cell suspensions from blood, bone marrow, lymph nodes, and spleens were prepared as
previously described [58]. We have used the same protocol to process bone marrow and blood
samples. Briefly, the samples were first 1:1 diluted with 1XPBS or HBSS, and then the diluted
samples were overlaid on lymphocyte separation medium Lympholyte-H (Human, Cedarlane,
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Ontario, Canada). After centrifugation at 800 x g for 20 min at room temperature (25˚C), with
centrifuge brake on OFF position, the middle opaque fluid containing the PBMC/BM cells was
collected. The cells were washed with R10 medium three times before cryopreservation in liq-
uid nitrogen freezers. Ileum lamina propria, colon lamina propria, and liver were collected
from the macaques as previously described with modification[23, 57–59]. Briefly, the tissues
were first rinsed 2–3 times with 1XHBSS containing 5mM EDTA and 1-2mM DTT to remove
mucous and intestinal intraepithelial lymphocytes (IEL) (only for the gut). The tissues were
then cut into small pieces and incubated with Liberase (Roche) at 37˚C for 30 min. After
enzyme digestion, the tissue chunks were mashed through a syringe end and filtered through a
100 μm cell strainer. After washes, the cells were re-suspended in 40% Percoll, and underlaid
with 80% Percoll. The cells in the interface were collected after spinning down for 20min, 800
x g at room temperature (25˚C), with centrifuge brake on OFF position. The cells were cryo-
preserved in liquid nitrogen freezers after three washes with R10 medium. All cell samples
used in this study were cryopreserved.
4. Antibodies and flow cytometric analysis of MDSC and immune
activation of the tissue compartments
For flow cytometric analysis, the single-cell suspensions from different compartments were first
incubated with Fc Receptor blocking reagent (Miltenyi Biotec), and then stained with viability dye
(Invitrogen) and antibody mixtures including anti-CD45 (BD Pharmingen) to exclude the dead
and CD45 negative cells. For immune activation, the following antibodies were used: CD3-PE-Cy7,
CD4-BV605, CD8-APC-Cy7, CD14-V450, Ki67-APC, HLA-DR PE-Cy5, and CCR5-PE (BD Phar-
mingen); CD69-Alexa Fluor 700 (Biolegend); and CD38-FITC (STEMCELL Technologies). For
MDSC analysis, the following antibodies were used: CD3-PE-Cy7, CD4-BV605, CD14-V450,
Ki67-APC, HLA-DR-APC-Cy7, Lin-FITC (Lin1, BD Pharmingen); CD33-PE (Miltenyi Biotec),
CD15-Alexa700 and CD11b-PE-Cy5 (Biolegend). CM9 Dextramer was obtained from Immudex
(Denmark). For gag-P27 staining of MDSCs, besides the antibodies listed above, CD2-PE-Cy7 (BD
Pharmingen), CD68-Perp-cy5.5, and P27 antibody [60] (clone KK64, cat#2321, from NIH AIDS
reagent program) were also added to the panel. For gag-P27 staining, we have incubated the cells
for 2 hrs with 5 μl of human TruX blocker (Biolegend), and 2 μl of human IgG (1 mg/ml, from
R&D systems) before adding the surface antibody mixture. We also extended the P27 staining over-
night on ice. An LSRII flow cytometer was used for data acquisition, and FlowJo software (Tree Star
Inc.) was used for data analyses. The gating strategies for MDSCs were shown in Fig 1A and Fig 2A.
5. Flow cytometric sorting and SIV viral RNA detection
MDSCs were sorted by using a BD FACSAria (BD Biosciences) with the following markers:
CD3–HLA-DR–CD11b+CD33+ cells from live PBMCs (purity greater than 95%) or spleen.
CD4+ T cells were sorted as positive controls. The sorted CD4+ T cells were either serially
diluted in 10-fold dilutions or directly put into Trizon. After Trizon-lysis, the sorted cells were
then subjected to RNA isolation, reverse transcription, and qPCR reactions to detect the rela-
tive expression levels of SIVgag, spliced SIV rev, tat, nef, and vif, CD3, CD4, and GAPDH in
MDSCs and CD4+ T cells (ABI, Bioline) [58]. Taqman probe and primer sets for gag[61],
CD3, CD4, and GAPDH were used (ABI). Spliced SIV rev, tat, nef, and vif primers and probes
were synthesized at ABI, and multiplexed to detect the rev, tat, nef, and vif targets simulta-
neously [62]. Each PCR mixture contained 5 μl of cDNA, 10 μl of 2X universal PCR master
mix (ABI) or SensiFast probe kit (Bioline USA Inc.), 1 μl of primer/probe set. All PCR were
run using ABI 7500 with program consisting of 2 min at 50˚C, 10 min at 95˚C, and then fol-
lowed by 45 cycles of 15 sec at 95˚ C, and 1 min at 60˚C. Relative mRNA expression levels
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were compared by the comparative threshold cycle (Ct) method of relative quantitation (Perki-
nElmer User Bulletin no. 2) as described[63], except in cases where standards were available to
determine copy number, as indicated. As each cycle represents a doubling (log2), subtracting
Ct for GAPDH is essentially taking a ratio to or normalizing to the GAPDH housekeeping
gene.
6. Chemotaxis assays
The 96-well ChemoTx chemotaxis system (NeuroProbe Inc., 5um pore) was used for chemo-
taxis assays. The lower wells were blocked with 301 μl of 1% BSA for 30 min at room tempera-
ture, which was aspirated and replaced with 301 μl of plasma from pre- or post-infected
macaques as test samples. 301 μl of RPMI-1640 /0.1% BSA buffer was included in the experi-
ments as buffer controls. Single cell suspensions from bone marrow of naive macaques were
collected and 2 x 105 bone marrow single cell suspensions were re-suspended in 50 μl RPMI-
1640 /0.1% BSA and loaded above the membrane. After incubation for 2 hr at 37˚C, 5% CO2,
the top wells were removed with a scraper and the migrated cells in the bottom wells were
counted, and stained with the antibody mixture: CD3-PE-Cy7, CD14-V450, HLA-DR-APC-
Cy7, Lin-FITC, CD33-PE, and CD11b-PE-Cy5, Cd45-Alexa 700, and yellow viability dye.
50 μl of CountBright absolute counting beads (Molecular Probes) were added to each tube
before data acquisition using an LSRII flow cytometer, and FlowJo software (Tree Star Inc.)
was used for data analyses. Chemotaxis index was defined as the ratio of the absolute cell num-
bers in the test samples over the absolute cell numbers in the buffer control samples.
7. Statistical analyses
We performed statistical analyses with Prism version 6 (Graph Pad). One-way ANOVA with
Dunn’s multiple comparison corrections, and Mann-Whitney, and Wilcoxon tests were used
as shown in the figures. Spearman analysis was used for correlations. A two-sided significance
level of 0.05 was used for all analyses.
Supporting information
S1 Fig. Gating strategy of CD14high and CD14 intermediate MDSCs in SIV chronically
infected bone marrow (14-month post-infection) and naïve bone marrow.
(TIF)
S2 Fig. CD14+ subpopulation in SIV-infected and naive bone marrows. CD14+ subpopula-
tion within the CD45+CD3- live mononuclear cell gate from two cohorts of naïve macaques
(with 28 and 12 animals separately), and one cohort of SIV chronically infected macaques (12
animals) were shown.
(TIF)
S3 Fig. The frequencies of CD14+ and Lin-CD15+MDSC subsets in freshly-isolated vs. cryo-
preserved/thawed bone marrow (BM) and PBMC samples were compared. BM and PBMC
samples from SIVmac251-infected and naïve macaques were divided into two aliquots; one
was immediately stained and analyzed by flow-cytometry, while the other were cryopreserved
in liquid N2 and thawed for testing 4–5 months later. SIV-infected BM (n = 6), PBMC(n = 7),
and naïve BM (n = 12), PBMC (n = 5) samples were used for comparisons. (A-B) The frequen-
cies of CD14+MDSCs in the BM samples did not significantly change in the SIV-infected and
naïve animals, where the frequencies of Lin-CD15+MDSCs significantly decreased after cryo-
preservation and thawing. (C) 70–80% of CD14+MDSCs were maintained in the frozen naïve
and SIV-infected BM samples, whereas only 20% of Lin-CD15+MDSCs were detected after
Myeloid-derived suppressor cell reduction in bone marrow contributes to HIV pathogenesis
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006395 May 12, 2017 22 / 28
cryopreservation and thawing in both the infected and naïve animals. No difference in preser-
vation was observed between SIV-infected and naïve animals for either subset. (D-F) The fre-
quencies of CD14+MDSCs in the PBMC samples did not significantly change in the SIV-
infected animals after cryopreservation and thawing. The frequencies of Lin-CD15+ and
CD14+MDSCs in the PBMC of the naïve animals, and the frequencies of Lin-CD15+ MDSCs
in the PBMC of SIV-infected animals were too low to adequately assess the effect on cryopres-
ervation, although the direction of the change in CD15+ Lin- MDSCs in PMBC (Panel E) was
in the direction of greater preservation in the SIV-infected than in the naïve populations, not
consistent with any greater loss in the SIV-infected cells.
Each data point represents one individual animal. The Wilcoxon matched-pairs signed rank
tests were used for comparisons.
(TIFF)
S4 Fig. The frequencies of CD14intermediate and CD14high MDSCs in the bone marrow of
chronically SIV-infected macaques inversely correlated with plasma viral loads; but only
CD14intermediate, but not CD14high, MDSCs positively correlated with CD4+ T cell preserva-
tion in the PBMC. Spearman analysis was used for correlations.
(TIF)
S5 Fig. qPCR analysis of SIV-gag in the flow cytometer sorted MDSCs and CD4+T cells
from the PBMCs of SIV-infected macaques. The Ct values of Gag, CD4, CD3, and GAPDH
from the sorted MDSCs and CD4+T cells were shown in A&B. Equal amounts of cDNA were
used to detect the expression levels of gag, CD4, CD3, and GAPDH except the CD3 in the
sorted CD4+T cells (100-fold less cDNA was added) using macaque-specific Taqman primer/
probes. The ratio of SIVgag /CD4 in CD4+T cells and MDSCs were shown in C.
(TIFF)
S6 Fig. qPCR analysis of SIV-gag in the flow cytometer sorted MDSCs and CD4+T cells
from the PBMCs of SIV-infected macaques. The Ct values of Gag, CD4, and GAPDH from
the sorted MDSCs and CD4+T cells were shown in A-C. Equal amounts of cDNA were used to
detect the expression levels of gag, and CD4 using macaque-specific Taqman primer/probes.
The ratio of SIVgag expression level in MDSCs vs SIV gag expression level in CD4+T cells is
shown in D, calculating using 2^ (Δgag-GAPDH) for MDSCs vs CD4+T cells. The ratio of
CD4 expression level in MDSCs vs CD4 expression level in CD4+T cells were shown also in D
using the similar calculation method. MDSCs had a 50-fold lower expression level of CD4.
Thus, the level of CD4+ T cell contamination in the MDSC population is 50-fold too low to
account for the SIVgag present.
(TIF)
S7 Fig. qPCR analysis of SIV mRNA in the flow cytometer sorted MDSCs and CD4+ T cells
from the PBMC or BM samples of the SIV-infected macaques. Three independent experi-
ments are shown. MDSCs and CD4+ T cells from the PBMC or bone marrow samples of the
SIVmac251 chronically infected animals were sorted as described in Fig 5A. After RNA isola-
tion and cDNA synthesis, each of the CD4+ T and MDSC samples was subjected to qPCR
analysis for SIVgag and/or spliced SIV mRNA, CD3, or CD4, and GAPDH using the same
amounts of cDNA for that sample. (A-B) In this experiment, four PBMC specimens from the
SIVmac251-infected macaques were analyzed for unspliced SIVgag and spliced SIV mRNA.
The threshold cycles of spliced and unspliced viral mRNA in T cells and MDSCs of the
infected macaques are shown in A-B. Lower threshold cycle value indicates higher expression
level of the target sequence. For CD3, if there was no amplification signal after 45 cycles, Ct
value of 45 was assigned to the tested sample. (C) In another independent experiment, MDSCs
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and CD4+ T cells from the bone marrow samples of the six SIV-infected animals were sorted.
For the sorted CD4+ T cells, the samples were serially diluted (10–fold) before the RNA isola-
tion. Spliced SIV mRNA and CD3 mRNA from six MDSC samples and one example of CD4+
T cells were analyzed. The detection limit is 90 to 900000 CD4+ T cells. Of the 4 animals with
no detectable CD3 contamination (shown in magenta squares), 3 had clear spliced mRNA
expression. (D) In the third independent experiment, MDSCs and CD4+ T cells from the
PBMC of six SIV-infected animals were sorted. For the sorted CD4+ T cells, the samples were
serially diluted (10–fold) before the RNA isolation. Gag and CD4 were shown in Fig 5D. For
CD3, if there was no amplification signal after 45 cycles, Ct value of 45 was assigned to the
tested sample. Black dots in C are CD4+ T cells as positive control titration curve, while red or
magenta squares are the MDSCs plotted on the same scale. Black dots in D are CD4+ T cells as
positive control titration curve, while red squares are the MDSCs plotted on the same scale.
The sensitivity to detect T cell contamination in these four animals was from 27 and 118 CD4+
T cells.
(TIFF)
S8 Fig. Flow cytometric detection of gag-P27+ MDSCs and CD4+T cells in the bone mar-
row of SIV-infected or naive animals. Flow cytometric plots of P27 staining (A), and sum-
mary of P27+ % within CD4+T cells, and MDSCs (B) from one experiment with 1 SIV-infected
and 4 naïve animals were shown.
(TIF)
S9 Fig. Decreased Lin- CD15+MDSCs in bone marrow were not associated with increased
immune activation except in PBMC. Spearman analysis was used for correlations. The corre-
lations between the frequency of Lin- CD15+MDSCs and the Ki67+CD8+ T cell frequencies in
the SIV-infected bone marrow (A), PBMC (B), spleen (D), Axillary LN (E) and Mesenteric LN
(F), but not liver (C), ileum LP (G) or colon LP (H) were shown. Each data point represents
one animal.
(TIF)
S10 Fig. The frequencies of MDSCs were initially significantly increased 4 months post-
SHIVSF162P4 infection, and reverted to normal 11 months post-infection.
(TIF)
S1 Table. Information on the macaques used in this study.
(PPTX)
S2 Table. The R and P values of Spearman’s analysis among the CD14+MDSC from differ-
ent compartments.
(PPTX)
S3 Table. The R and P values of Spearman’s analysis among the Lin-CD15+MDSC from
different compartments.
(PPTX)
S4 Table. The R and P values of Spearman’s analysis among the CM9 Dextramer+ fre-
quency within the total CD8+T cells from different compartments.
(PPTX)
S5 Table. The R and P values of Spearman’s analysis among the Ki67+ frequency within
the total CD8+T cells from different compartments.
(PPTX)
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